Page last updated: 2024-09-03

5-hydroxymethylomeprazole and ticlopidine

5-hydroxymethylomeprazole has been researched along with ticlopidine in 1 studies

Compound Research Comparison

Studies
(5-hydroxymethylomeprazole)
Trials
(5-hydroxymethylomeprazole)
Recent Studies (post-2010)
(5-hydroxymethylomeprazole)
Studies
(ticlopidine)
Trials
(ticlopidine)
Recent Studies (post-2010) (ticlopidine)
54171510,2891,8934,671

Protein Interaction Comparison

ProteinTaxonomy5-hydroxymethylomeprazole (IC50)ticlopidine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.382
Cytochrome P450 2D6Homo sapiens (human)6.2928
Alpha-2B adrenergic receptorHomo sapiens (human)0.304
Alpha-2C adrenergic receptorHomo sapiens (human)1.175
Cytochrome P450 2B6Homo sapiens (human)0.405
Cytochrome P450 2C19Homo sapiens (human)0.6678
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BL; Chen, Y; Fan, L; Hu, DL; Li, Q; Li, YL; Ouyang, DS; Tan, ZR; Tu, JH; Wang, D; Wang, LS; Zhang, W; Zhou, HH1

Trials

1 trial(s) available for 5-hydroxymethylomeprazole and ticlopidine

ArticleYear
Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Genotype; Humans; Hydroxylation; Male; Omeprazole; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Spectrophotometry, Ultraviolet; Sulfoxides; Ticlopidine; Young Adult

2009